Elevated circulating levels of inflammatory biomarkers, i.e., IL6, TNFα, C-reactive protein (CRP), have been associated with a greater risk for several types of cancer and cancer prognosis, including breast [8,9]. The gene discussed is CRP; the disease is cancer.